Cullinan Therapeutics
CGEM
#6338
Rank
S$0.85 B
Marketcap
$14.63
Share price
-6.27%
Change (1 day)
20.31%
Change (1 year)

Earnings for Cullinan Therapeutics (CGEM)

Earnings in 2024 (TTM): -S$0.25 Billion

According to Cullinan Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$0.26 Billion a decrease over its 2022 earnings that were of -S$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cullinan Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.25 Billion-4.06%
2023 -S$0.26 Billion44.28%
2022 -S$0.18 Billion94.45%
2021 -S$92.33 Million12.63%
2020 -S$81.98 Million